2025-04-01 2026-03-31 2026-03-31 Trading false The accounts were prepared in accordance with frs102 With an accountants report AbridgedAccounts This company is a private limited company 08453736 2026-03-31 08453736 2025-03-31 08453736 2024-03-31 08453736 2025-04-01 2026-03-31 08453736 2024-04-01 2025-03-31 08453736 uk-cd-pres:AllEntityOfficers 2025-04-01 2026-03-31 08453736 uk-cd-pres:AllEntityOfficers 2024-04-01 2025-03-31 08453736 uk-cd-pres:CompanySecretary1 2025-04-01 2026-03-31 08453736 uk-cd-pres:CompanySecretaryDirector1 2025-04-01 2026-03-31 08453736 uk-cd-pres:CompanySecretaryDirector1 2026-03-31 08453736 uk-cd-pres:Director1 2025-04-01 2026-03-31 08453736 uk-cd-pres:Director1 2026-03-31 08453736 uk-cd-pres:Director2 2025-04-01 2026-03-31 08453736 uk-cd-pres:Director2 2026-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2026-03-31 08453736 uk-cd-pres:AllPreferenceShares 2026-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2025-03-31 08453736 uk-cd-pres:AllPreferenceShares 2025-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2025-04-01 2026-03-31 08453736 uk-cd-pres:AllPreferenceShares 2025-04-01 2026-03-31 08453736 uk-cd-pres:AllOrdinaryShares 2024-04-01 2025-03-31 08453736 uk-cd-pres:AllPreferenceShares 2024-04-01 2025-03-31 08453736 uk-cd-pres:RegisteredOffice 2025-04-01 2026-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2026-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2025-04-01 2026-03-31 08453736 uk-cd-pres:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 08453736 uk-cd-pres:EntityBankers 2025-04-01 2026-03-31 08453736 uk-cd-pres:EntityLawyersOrLegalAdvisers 2025-04-01 2026-03-31 08453736 uk-countries:UnitedKingdom 2025-04-01 2026-03-31 08453736 uk-countries:Europe 2025-04-01 2026-03-31 08453736 uk-countries:NorthAmerica 2025-04-01 2026-03-31 08453736 uk-countries:OtherCountriesRegions 2025-04-01 2026-03-31 08453736 uk-countries:UnitedKingdom 2024-04-01 2025-03-31 08453736 uk-countries:Europe 2024-04-01 2025-03-31 08453736 uk-countries:NorthAmerica 2024-04-01 2025-03-31 08453736 uk-countries:OtherCountriesRegions 2024-04-01 2025-03-31 08453736 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2025-04-01 2026-03-31 08453736 uk-gaap-pt:LeasedTangibleFixedAssets 2025-04-01 2026-03-31 08453736 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2024-04-01 2025-03-31 08453736 uk-gaap-pt:LeasedTangibleFixedAssets 2024-04-01 2025-03-31 08453736 uk-gaap-pt:OwnedAssets 2025-04-01 2026-03-31 08453736 uk-gaap-pt:LeasedAssets 2025-04-01 2026-03-31 08453736 uk-gaap-pt:OwnedAssets 2024-04-01 2025-03-31 08453736 uk-gaap-pt:LeasedAssets 2024-04-01 2025-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2026-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2025-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2025-04-01 2026-03-31 08453736 uk-gaap-pt:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 08453736 uk-gaap-pt:NetGoodwill 2025-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2025-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2025-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2025-03-31 08453736 uk-gaap-pt:NetGoodwill 2025-04-01 2026-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2025-04-01 2026-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2025-04-01 2026-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2025-04-01 2026-03-31 08453736 uk-gaap-pt:NetGoodwill 2026-03-31 08453736 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2026-03-31 08453736 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2026-03-31 08453736 uk-gaap-pt:OtherResidualIntangibleAssets 2026-03-31 08453736 uk-gaap-pt:Buildings 2025-04-01 2026-03-31 08453736 uk-gaap-pt:Land 2025-04-01 2026-03-31 08453736 uk-gaap-pt:LandBuildings 2025-03-31 08453736 uk-gaap-pt:PlantMachinery 2025-03-31 08453736 uk-gaap-pt:FurnitureFittings 2025-03-31 08453736 uk-gaap-pt:FurnitureFittings 2025-03-31 08453736 uk-gaap-pt:OfficeEquipment 2025-03-31 08453736 uk-gaap-pt:Vehicles 2025-03-31 08453736 uk-gaap-pt:LandBuildings 2025-04-01 2026-03-31 08453736 uk-gaap-pt:PlantMachinery 2025-04-01 2026-03-31 08453736 uk-gaap-pt:FurnitureFittings 2025-04-01 2026-03-31 08453736 uk-gaap-pt:FurnitureFittings 2025-04-01 2026-03-31 08453736 uk-gaap-pt:OfficeEquipment 2025-04-01 2026-03-31 08453736 uk-gaap-pt:Vehicles 2025-04-01 2026-03-31 08453736 uk-gaap-pt:LandBuildings 2026-03-31 08453736 uk-gaap-pt:PlantMachinery 2026-03-31 08453736 uk-gaap-pt:FurnitureFittings 2026-03-31 08453736 uk-gaap-pt:OfficeEquipment 2026-03-31 08453736 uk-gaap-pt:Vehicles 2026-03-31 08453736 uk-gaap-ptx:AdministrativeExpenses 2025-04-01 2026-03-31 08453736 uk-gaap-ptx:AdministrativeExpenses 2024-04-01 2025-03-31 08453736 uk-gaap-ptx:CostSales 2025-04-01 2026-03-31 08453736 uk-gaap-ptx:CostSales 2024-04-01 2025-03-31 08453736 uk-gaap-ptx:DistributionCosts 2025-04-01 2026-03-31 08453736 uk-gaap-ptx:DistributionCosts 2024-04-01 2025-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2026-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2025-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2026-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2025-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2026-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2025-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2026-03-31 08453736 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2025-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments 2026-03-31 08453736 uk-gaap-pt:CurrentFinancialInstruments 2025-03-31 08453736 uk-gaap-pt:WithinOneYear 2026-03-31 08453736 uk-gaap-pt:BetweenOneTwoYears 2026-03-31 08453736 uk-gaap-pt:BetweenTwoFiveYears 2026-03-31 08453736 uk-gaap-pt:MoreThanFiveYears 2026-03-31 08453736 uk-gaap-pt:AfterOneYear 2026-03-31 08453736 uk-gaap-pt:WithinOneYear 2025-03-31 08453736 uk-gaap-pt:BetweenOneTwoYears 2025-03-31 08453736 uk-gaap-pt:BetweenTwoFiveYears 2025-03-31 08453736 uk-gaap-pt:MoreThanFiveYears 2025-03-31 08453736 uk-gaap-pt:AfterOneYear 2025-03-31 08453736 uk-gaap-pt:ShareCapital 2026-03-31 08453736 uk-gaap-pt:SharePremium 2026-03-31 08453736 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2026-03-31 08453736 uk-gaap-pt:RevaluationReserve 2026-03-31 08453736 uk-gaap-pt:OtherReservesSubtotal 2026-03-31 08453736 uk-gaap-pt:ShareCapital 2025-03-31 08453736 uk-gaap-pt:SharePremium 2025-03-31 08453736 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2025-03-31 08453736 uk-gaap-pt:RevaluationReserve 2025-03-31 08453736 uk-gaap-pt:OtherReservesSubtotal 2025-03-31 08453736 1 2025-04-01 2026-03-31 08453736 2 2025-04-01 2026-03-31 08453736 uk-cd-pres:FRS102 2025-04-01 2026-03-31 08453736 uk-cd-pres:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 08453736 uk-cd-pres:FullAccounts 2025-04-01 2026-03-31 08453736 uk-cd-pres:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure
 
 
 
 
 
 
 
C. B. Therapy Solutions Limited
 
 
Company Registration Number
08453736
 
 
Report of the Directors and
Abridged Unaudited Financial Statements
 
 
Period of accounts
 
Start date 01/04/2025
 
End date 31/03/2026
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 1
C. B. Therapy Solutions Limited
 
Contents of the Financial Statements
for the Period Ended 31 March 2026
 
 
Page
Company Information 3
 
Report of the Accountants 4
 
Abridged Balance Sheet 5 - 6
 
Notes to the Financial Statements 7 - 10
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 2
C. B. Therapy Solutions Limited
Company Information
for the Period Ended 31 March 2026
 
Directors Mrs Christine Vanessa Board
Mr Keith Robert Board
 
Company secretary Mr Keith Robert Board
 
Registered office 19 Long Pasture Road
Llanwern
Newport
Wales. NP18 2DL.
 
Company Registration Number 08453736
 
Accountants Name Christopher John Edwards & Co. Limited
Address 17 Vayre Close
Chipping Sodbury
Bristol
BS37 6NT
South Gloucestershire
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 3
C. B. Therapy Solutions Limited
 
Accountants' Report
for the Period Ended 31 March 2026
 
Independent accountants' report
 
Report to the directors on the preparation of the unaudited statutory accounts of the company for theperiod ended 31 March 2026. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of the company for the period ended 31 March 2026 as set out on pages 3 to 10 which comprise of the Balance Sheet and the related notes from the companys accounting records and from information and explanations you have given us. This report is made solely to the Board of Directors of the company, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the
accounts of the company and state those matters that we have agreed to state to the Board of Directors
of the company, as a body, in this report. To the fullest extent permitted by law, we do not accept or
assume responsibility to anyone other than the company and its Board of Directors as a body for our
work or for this report.
 
It is your duty to ensure the company has kept adequate accounting records and to prepare statutory
accounts that give a true and fair view of the assets, liabilities, financial position and profit/(loss) of
the company. You consider the company is exempt from the statutory audit requirement for the
period.
We have not been instructed to carry out an audit of the financial statements. For this reason, we
have not verified the accuracy or completeness of the accounting records or information and
explanations you have given to us and we do not, therefore, express any opinion on the financial
statements.
 
 
 
 
 
 
 
Christopher John Edwards & Co. Limited
17 Vayre Close
Chipping Sodbury
Bristol
BS37 6NT
South Gloucestershire
 
Date 2026-07-14
Page 4
C. B. Therapy Solutions Limited
Balance Sheet
for the Period Ended 31 March 2026
Company registration number 08453736
2026 2,025
Notes £ £
Fixed assets
Tangible fixed assets 2 120 160
_______ _______
Total fixed assets 120 160
Current assets
Stocks 3 150 150
Cash at bank and in hand 5,583 2,497
_______ _______
Total current assets/(liabilities) 5,733 2,647
Creditors
Creditors - amounts falling
due within one year 5 4,091 3,243
_______ _______
Net current assets 1,642 (596)
_______ _______
Total assets less current liabilities 1,762 (436)
_______ _______
Net assets/(liabilities) 1,762 (436)
Capital and reserves
Called up share capital 6 2 2
Profit and loss account 7 1,760 (438)
____ ____
Total shareholders funds 1,762 (436)
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 5
C. B. Therapy Solutions Limited
 
Balance Sheet
for the Period Ended 31 March 2026
 
 
 
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The option not to file the profit and loss account has been taken.
 
For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
 
The financial statements were approved by the Board of Directors on 2026-07-15
 
SIGNED ON BEHALF OF THE BOARD BY
 
 
 
 
 
 
 
Name Mrs Christine Vanessa Board
Status Director
 
The notes form part of these financial statements
Average number of employees during period 1
 
 
 
 
 
 
 
Page 6
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2026
1. Accounting policies
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with the small companies regime.
Tangible fixed assets Depreciation
Depreciation is provided, after taking account of any grants receivable, at the following annual rates in order to write off each asset over its estimated useful life.
Office equipment 0
Stocks
Stocks and work-in-progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost includes all direct expenditure and an appropriate proportion of fixed and variable overheads.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Pension costs
The company operates a defined contribution pension scheme for employees. The annual contributionspayable are charged to the profit and loss account.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 7
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2026
2. Tangible fixed assets
Office Total
equipment
Cost £ £
At 1 April 2025 1,334 1,334
____ ____
At 31 March 2026 1,334 1,334
Depreciation
At 1 April 2025 1,174 1,174
Charge for year 40 40
____ ____
At 31 March 2026 1,214 1,214
Net book value
At 31 March 2026 120 120
At 31 March 2025 160 160
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 8
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2026
3. Stocks 2026 2,025
Finished goods 150 150
Total 150 150
4. Debtors 2026 2,025
_ _
Total
5. Creditors amounts falling due within one year 2026 2,025
Corporation tax 3,080 2,943
Other taxation and social security 300 300
Other creditors 711
____ ____
Total 4,091 3,243
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 9
C. B. Therapy Solutions Limited
Notes to the Financial Statements
for the Period Ended 31 March 2026
6. Share capital 2026 2,025
Allotted, called up and paid £ £
Ordinary shares of £ 1.00 each 2 2
_ _
Total 2 2
7. Reserves/Retained profit
Retained profit reconciliation £
Reserves at 1 April 2025 (438)
Profit/(Loss) for year 13,090
Dividends paid 10,892
____
Retained Profit/(Loss) at 31 March 2026 1,760
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 10